Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 10161-10170 of 13616

Page
per page
  1. SJB3-019A
    B1307 SJB3-019A
    Target: USP
    Summary: Usp1 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.85 mg/mL
  2. Zonisamide sodium
    B1231 Zonisamide sodium
    Summary: Antiepileptic drug
      Soluble in DMSO
  3. Fluticasone propionate
    B2096 Fluticasone propionate
    Target: Glucocorticoid Receptors
    Summary: High affinity, selective glucocorticoid receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥18.5 mg/mL
  4. Golgicide A
    B1385 Golgicide A
    Summary: GBF1 inhibitor, potent, reversible and highly specific
      insoluble in H2O; ≥12.95 mg/mL
  5. Primaquine Diphosphate
    B1820 Primaquine Diphosphate
    Summary: antimalarial agent,blocks protein synthesis
      insoluble in EtOH; ≥18.85 mg/mL
  6. Gliclazide
    B2195 Gliclazide
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: Potassium channel inhibitor
      insoluble in H2O; ≥15.6 mg/mL
  7. Domperidone
    B1481 Domperidone
    Summary: Drug for gastroparesis
      ≥21.3 mg/mL
  8. Gilteritinib
    A4691 Gilteritinib
    Summary: A FLT3 kinase inhibitor for the treatment of acute myeloid leukemia
      ≥5.68 mg/mL
  9. 5,6-Dihydrouracil
    C6574 5,6-Dihydrouracil
    Summary: A uracil metabolite for identifying dihydropyrimidine dehydrogenase (DPD) deficiency
      ≥22.1 mg/mL
  10. Dehydroacetic acid
    C6741 Dehydroacetic acid
    Summary: A pyrone derivative with antibacterial, antifungal, and phytotoxic activity
      ≥31.5 mg/mL

Items 10161-10170 of 13616

Page
per page